Schizophrenia in Canada
![](/content/dam/phac-aspc/images/services/publications/diseases-conditions/schizophrenia-canada/schizophrenia-canada-thumbnail-eng.jpg)
Download the alternative format
(PDF format, 127 MB / KB, 1 page)
Organization: Public Health Agency of Canada
Published: 2020-05-25
Schizophrenia is a psychotic disorder that can affect the way a person interacts with and understands the world.
Symptoms of active schizophrenia include delusions, hallucinations, disorganized speech and/or behaviour, and impaired cognitive ability.Footnote 1 The severity, duration and frequency of these symptoms can cause social and occupational challenges.
Causes of schizophrenia are not fully understood. Structural changes in the brain and genetics, combined with lifestyle and environmental factors, may play a role.
While there is no cure for schizophrenia, programs and treatments are available to help manage symptoms in the community and at work. Reducing public misunderstanding and fear of the disease can reduce stigma and support affected individuals.Footnote 2
According to national data (2016-2017), of Canadians aged 10+:Footnote 3
- 1 out of 100 were living with diagnosed schizophrenia:
- 56% were men
- 44% were women
- About 30% of newly diagnosed cases were aged 20 to 34 years old.
- Among this group, the rate of new cases was more than 2x higher in men compared to women. In general, men experience an earlier onset of schizophrenia than women.
- The all-cause mortality rate in people diagnosed with schizophrenia was 2.8x higher than those without.
- Of people aged 1+, over 147,500 Canadians used health services for schizophrenia.Footnote 3
- 60% were men
- 40% were women
Have rates of schizophrenia changed over time?
Between 2002-2016:
- The number of Canadians living with diagnosed schizophrenia increased by an average of 3% per year.Footnote 3
- The number of new cases declined during this period.Footnote 3Footnote 4
The Canadian Chronic Disease Surveillance System (CCDSS) is supported by a pan-Canadian partnership between the Public Health Agency of Canada and all provinces and territories. Schizophrenia data in CCDSS are updated biennially.
Learn more about schizophrenia:
Visit Canada.ca and Search ‘Schizophrenia’
Like Us @HealthyCdns
Follow Us @GovCanHealth
Get Data Canadian Chronic Disease Surveillance System - Public Health Infobase
More Schizophrenia Society of Canada | World Health Organization
Notes
Footnotes
- Footnote 1
-
American Psychiatric Association. Schizophrenia spectrum and other psychotic disorders. In Diagnostic and statistical manual of mental disorders (5th ed.). 2013 (Retrieved November 2019) https://dsm.psychiatryonline.org/doi/full/10.1176/appi.books.9780890425596.dsm02
- Footnote 2
-
Government of Canada. The human face of mental health and mental illness in Canada. 2006. (Retrieved January 2020) www.phac-aspc.gc.ca/publicat/human-humain06/pdf/human_face_e.pdf
- Footnote 3
-
Canadian Chronic Disease Surveillance System (CCDSS), August 2019. Schizophrenia (aged 10+); and use of health services for schizophrenia (aged 1+). CCDSS data are based on people with diagnosed schizophrenia who had contact with the health system during the data collection period, which may underestimate the total number of people diagnosed with schizophrenia during a lifetime. Saskatchewan data from year 2016-2017 were not available. Nunavut data were excluded before 2005–2006. Yukon data were excluded before 2010–2011. Crude rates were based on randomly rounded counts to an adjacent multiple of 10.
- Footnote 4
-
Declining of incidence rates of schizophrenia may be influenced by changes in population health status, clinical diagnostic and screening practices, or administrative practices within provinces, such as physician billing methods. For more information: Hamm, N.C., Pelletier, L., Ellison, J., Tennenhouse, L., Reimer, K., Paterson, J.M., Puchtinger, R., Bartholomew, S., Phillips, K.A.M., and Lix, L.M. 2019. Original quantitative research trends in chronic disease incidence rates from the Canadian Chronic Disease Surveillance System. Health promotion and chronic disease prevention in Canada: research, policy and practice, 39(6–7), 216.
Her Majesty the Queen in Right of Canada, as represented by the Minister of Health, 2020 Cat.: HP35-131/2020E-PDF | ISBN: 978-0-660-34377-8 | Pub.: 190635
Page details
- Date modified: